Institute for Science, Ethics and Innovation

Last updated

Institute for Science, Ethics and Innovation
John Sulston and John Harris.jpg
John Sulston and John Harris, Chair and Director of the Institute for Science, Ethics and Innovation
Chair John Sulston
Key people John Sulston, John Harris
Location,
United Kingdom
Website http://www.isei.manchester.ac.uk

The Institute for Science, Ethics and Innovation (iSEI) is a research institute founded at the University of Manchester in 2007 with a mission to examine the role and moral responsibilities of science, technology and innovation in the contemporary world. Chaired by the Nobel laureate John Sulston (formerly the founding director of the Sanger Institute) and directed by the bioethicist John Harris, iSEI performs multi-disciplinary research across four broad areas: What is Science For? Who Owns Science? How Should Science be Used? and the Ethics of Emerging Technologies.

Contents

Funded by a Wellcome Trust Biomedical Ethics Strategic Award, iSEI has embarked on a 5-year research programme on ‘The Human Body: Its Scope, Limits and Future’, [1] starting in 2009. This work will follow five strands within iSEI's existing research portfolio: • Human Biomaterials • Genethics • Reproduction • Enhancement • Methods in Bioethics

Publications

The Manchester Manifesto

The Manchester Manifesto. Manchester Manifesto.png
The Manchester Manifesto.

In 2009, the Institute for Science, Ethics and Innovation published the Manchester Manifesto, the signatories of which include Nobel laureates Joseph Stiglitz (also director of Brooks World Poverty Institute), John Sulston. [2] The manifesto raised questions about the ownership of science and the rationale for strict intellectual property rights [3] and was widely reported in the British media, with articles in the Financial Times, [4] The Times, [5] The Guardian [6] accompanied by interviews of the Nobel duo in the BBC's Today programme. [7] The Chartered Institute of Patent Attorneys welcomed aspects of the manifesto, but criticised the authors views as being "ill-informed and misleading", [8] leading the authors to respond "it was not the purpose of the Manchester Manifesto to abolish intellectual property, nor yet its governance by laws; but to bring these far more into line with the public interest." [9]

Related Research Articles

<span class="mw-page-title-main">Harry Kroto</span> English chemist

Sir Harold Walter Kroto, known as Harry Kroto, was an English chemist. He shared the 1996 Nobel Prize in Chemistry with Robert Curl and Richard Smalley for their discovery of fullerenes. He was the recipient of many other honors and awards.

<span class="mw-page-title-main">Intellectual property</span> Ownership of creative expressions and processes

Intellectual property (IP) is a category of property that includes intangible creations of the human intellect. There are many types of intellectual property, and some countries recognize more than others. The best-known types are patents, copyrights, trademarks, and trade secrets. The modern concept of intellectual property developed in England in the 17th and 18th centuries. The term "intellectual property" began to be used in the 19th century, though it was not until the late 20th century that intellectual property became commonplace in most of the world's legal systems.

<span class="mw-page-title-main">Nobel Prize in Physiology or Medicine</span> One of five Nobel Prizes established in 1895 by Alfred Nobel

The Nobel Prize in Physiology or Medicine is awarded yearly by the Nobel Assembly at the Karolinska Institute for outstanding discoveries in physiology or medicine. The Nobel Prize is not a single prize, but five separate prizes that, according to Alfred Nobel's 1895 will, are awarded "to those who, during the preceding year, have conferred the greatest benefit to humankind". Nobel Prizes are awarded in the fields of Physics, Chemistry, Physiology or Medicine, Literature, and Peace.

<span class="mw-page-title-main">University of Manchester</span> Public university in Manchester, England

The University of Manchester is a public research university in Manchester, England. The main campus is south of Manchester City Centre on Oxford Road. The university owns and operates major cultural assets such as the Manchester Museum, The Whitworth art gallery, the John Rylands Library, the Tabley House Collection and the Jodrell Bank Observatory – a UNESCO World Heritage Site.

<span class="mw-page-title-main">John Sulston</span> British biologist and academic (1942–2018)

Sir John Edward Sulston was a British biologist and academic who won the Nobel Prize in Physiology or Medicine for his work on the cell lineage and genome of the worm Caenorhabditis elegans in 2002 with his colleagues Sydney Brenner and Robert Horvitz. He was a leader in human genome research and Chair of the Institute for Science, Ethics and Innovation at the University of Manchester. Sulston was in favour of science in the public interest, such as free public access of scientific information and against the patenting of genes and the privatisation of genetic technologies.

Humanism and Its Aspirations is the most recent of the Humanist Manifestos, published in 2003 by the American Humanist Association (AHA). The newest one is much shorter, listing six primary beliefs, which echo themes from its predecessors:

<span class="mw-page-title-main">Wellcome Sanger Institute</span> British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

The Adelphi Charter on Creativity, Innovation and Intellectual Property is the result of a project commissioned by the Royal Society for the encouragement of Arts, Manufactures & Commerce, London, England, and is intended as a positive statement of what good intellectual property policy is. The Charter was issued in 2004.

<span class="mw-page-title-main">David Koepsell</span>

David Richard Koepsell is an American author, philosopher, attorney, and educator whose recent research focuses on how ethics and public policy deal with emerging science and technology. He has been a practicing attorney, been employed as an ontologist, been a university professor, and has lectured worldwide. He is a visiting professor of research ethics at National Autonomous University of Mexico, director of research and strategic initiatives at Comisión Nacional de Bioética (CONBIOETICA) Mexico, an adjunct professor at University at Buffalo and a senior fellow and education director of the Center for Inquiry Transnational, based in Amherst, New York.

<span class="mw-page-title-main">Science and technology in Japan</span> Overview of science and technology in Japan

Science and technology in Japan has helped fuel the rapid industrial and economic development of the country. Japan has a long history and tradition for scientific research and development, stretching as far back as the Meiji period.

<span class="mw-page-title-main">Science and technology in Argentina</span>

The most important aspects of science and technology in Argentina are concerned with medicine, nuclear physics, biotechnology, nanotechnology, space and rocket technology and several fields related to the country's main economic activities. According to the World Bank, Argentine exports in high-technology are products with high R&D intensity, such as in aerospace, computers, pharmaceuticals, scientific instruments, and electrical machinery. Benefiting from Latin America's highest literacy rates since shortly after President Domingo Faustino Sarmiento made primary education universally available in the 1860s and 1870s, Argentine researchers and professionals at home and abroad continue to enjoy a high standing in their fields. Argentine Bernardo Houssay was the first Latin American awarded with a Nobel Prize in sciences. Educated in a National University, Houssay went on to establish Argentina's National Research Council, a centerpiece in Argentine scientific and technological development, fifty years on. Many other Argentines have contributed to scientific development around the world, though sometimes having to emigrate to do so. Probably for that, the Argentine education is referred as the Latin American docta, which originates from the Latin docta (learned). Argentina was ranked 73rd in the Global Innovation Index in 2021.

A Hippocratic Oath for scientists is an oath similar to the Hippocratic Oath for medical professionals, adapted for scientists. Multiple varieties of such an oath have been proposed. Joseph Rotblat has suggested that an oath would help make new scientists aware of their social and moral responsibilities; opponents, however, have pointed to the "very serious risks for the scientific community" posed by an oath, particularly the possibility that it might be used to shut down certain avenues of research, such as stem cells.

<span class="mw-page-title-main">Andre Geim</span> Russian-born Dutch-British physicist

Sir Andre Konstantin Geim is a Russian-born Dutch-British physicist working in England in the School of Physics and Astronomy at the University of Manchester.

Legal scholars, economists, activists, policymakers, industries, and trade organizations have held differing views on patents and engaged in contentious debates on the subject. Critical perspectives emerged in the nineteenth century that were especially based on the principles of free trade. Contemporary criticisms have echoed those arguments, claiming that patents block innovation and waste resources that could otherwise be used productively, and also block access to an increasingly important "commons" of enabling technologies, apply a "one size fits all" model to industries with differing needs, that is especially unproductive for industries other than chemicals and pharmaceuticals and especially unproductive for the software industry. Enforcement by patent trolls of poor quality patents has led to criticism of the patent office as well as the system itself. Patents on pharmaceuticals have also been a particular focus of criticism, as the high prices they enable puts life-saving drugs out of reach of many people. Alternatives to patents have been proposed, such Joseph Stiglitz's suggestion of providing "prize money" as a substitute for the lost profits associated with abstaining from the monopoly given by a patent.

The Health Impact Fund is a proposed pay-for-performance mechanism that would provide a market-based solution to problems concerning the development and distribution of medicines globally. It would incentivize the research and development of new pharmaceutical products that make substantial reductions in the global burden of disease. The Health Impact Fund is the creation of a team of researchers led by the Yale philosopher Thomas Pogge and the University of Calgary economist Aidan Hollis, and is promoted by the non-profit organization Incentives for Global Health (IGH).

<span class="mw-page-title-main">John Harris (bioethicist)</span> British bioethicist and philosopher

John Morley Harris, FMedSci, FRSA, FRSB, is a British bioethicist and philosopher. He is the Lord Alliance Professor of Bioethics and Director of the Institute for Science, Ethics and Innovation at the University of Manchester.

<span class="mw-page-title-main">Jennifer Doudna</span> American biochemist and Nobel laureate (born 1964)

Jennifer Anne Doudna is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.

A biological patent is a patent on an invention in the field of biology that by law allows the patent holder to exclude others from making, using, selling, or importing the protected invention for a limited period of time. The scope and reach of biological patents vary among jurisdictions, and may include biological technology and products, genetically modified organisms and genetic material. The applicability of patents to substances and processes wholly or partially natural in origin is a subject of debate.

<span class="mw-page-title-main">Clarivate</span> American analytics company

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business / market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. In the academy and the scientific community, Clarivate is known for being the company which calculates the impact factor, using data from its Web of Science product family, that also includes services/applications such as Publons, EndNote, EndNote Click, and ScholarOne. Its other product families are Cortellis, DRG, CPA Global, Derwent, MarkMonitor, CompuMark, and Darts-ip, and also the various ProQuest products and services.

References

  1. "The Human Body: Its Scope, Limits and Future". The University of Manchester. Retrieved 22 April 2009.
  2. "Nobel duo ask: "Who owns science?"".
  3. "The Manchester Manifesto" (PDF).
  4. Cookson, Clive. "Manchester Manifesto asks: Who owns science?". Financial Times. Retrieved 8 June 2011.
  5. Jenkins, Russell (5 July 2008). "Medical research is 'hindered by out-of-date laws'". The Times. London.
  6. Sulston, John (26 November 2009). "How science is shackled by intellectual property". The Guardian. London. Retrieved 8 June 2011.
  7. "Has science become too commercial?". BBC News. 5 July 2008. Retrieved 8 June 2011.
  8. Prowse, Peter. "Patent profession welcomes Manchester Manifesto on science but slams 'misleading' comments on IP". CIPA News. Archived from the original on 27 September 2011. Retrieved 8 June 2011.
  9. "Responses".
  1. Institute for Science, Ethics and Innovation Archived 19 June 2012 at the Wayback Machine
  2. University of Manchester